Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer

CONCLUSIONS: Metastatic progression-free survival did not differ between men diagnosed with unfavorable risk non-metastatic prostate cancer who were treated with either radiation therapy or radical prostatectomy.PMID:34812728 | DOI:10.5489/cuaj.7525

Source: Canadian Urological Association Journal - November 23, 2021 Category: Urology & Nephrology Authors: David Guy Rachel Glicksman Roger Buckley Patrick Cheung Hans Chung Stanley Flax David Hajek Andrew Loblaw Gerard Morton Jeffery Noakes Les Spevack Joseph Chin George Rodrigues Source Type: research